FCF co-organizes, along with its accomplice YAFO Capital, the “ACCESS CHINA Biotech Discussion board” which will probably be held on-line on June 21st & 24th, 2022.
ACCESS CHINA Biotech Discussion board is a quarterly company entry occasion sequence between China and western biopharma. It’s the best deal-making platform for western pharma and biotech leaders seeking to enter or increase within the Chinese language market. The occasion will assist western biopharma firms to effectively current their property on-line in entrance of 500+ biopharma firms / 2000+ BD administrators and healthcare VCs in China. It creates invaluable BD alternatives by instantly connecting and assembly with the correct companions for growth, licensing or industrial collaborations. We anticipate to host 100 firm displays, 10 keynote speeches, 1000+ contributors, and 250+ 1×1 conferences. Licensing exercise in China has been steadily growing through the years.